Login to Your Account

ASCO Roundup

Tuesday, June 4, 2013

• NuCana BioMed Ltd., of Surrey, UK, presented interim results from the Phase I study (ProGem1) of its ProTide, NUC-1031.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription